TuisBSLN • SWX
add
Basilea Pharmaceutica AG Allschwil
Vorige sluiting
CHF 43,10
Dagwisseling
CHF 42,95 - CHF 43,50
Jaarwisseling
CHF 36,75 - CHF 48,75
Markkapitalisasie
567,71 m CHF
Gemiddelde volume
44,48 k
P/V-verhouding
7,70
Dividend-opbrengs
-
Primêre beurs
SWX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CHF) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 66,12 m | 81,84% |
Bedryfskoste | 7,98 m | 0,24% |
Netto inkomste | 28,43 m | 365,82% |
Netto winsgrens | 42,99 | 246,17% |
Wins per aandeel | — | — |
EBITDA | 26,89 m | 464,63% |
Effektiewe belastingkoers | -7,41% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CHF) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 120,71 m | 101,41% |
Totale bates | 257,76 m | 48,75% |
Totale aanspreeklikheid | 176,76 m | -3,56% |
Totale ekwiteit | 81,00 m | — |
Uitstaande aandele | 12,13 m | — |
Prys om te bespreek | 6,45 | — |
Opbrengs op bates | 25,30% | — |
Opbrengs op kapitaal | 33,85% | — |
Kontantvloei
Netto kontantverandering
| (CHF) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 28,43 m | 365,82% |
Kontant van bedrywe | 28,22 m | 840,82% |
Kontant van beleggings | -636,00 k | -97,21% |
Kontant van finansiering | -11,00 k | 99,95% |
Netto kontantverandering | 27,54 m | 213,29% |
Beskikbare kontantvloei | 17,85 m | 533,14% |
Meer oor
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
HUB
Gestig
2000
Webwerf
Werknemers
164
